Despite multimodal therapy, RA remains chronic and incurable, with current treatments focusing on inflammation suppression and bone damage mitigation through biologics (e.g., TNF-α inhibitors) and disease-modifying antirheumatic drugs (DMARDs). This evidence concerns the gene TNF and rheumatoid arthritis.